Free Trial
NASDAQ:VANI

Vivani Medical Q3 2023 Earnings Report

Vivani Medical logo
$1.24 +0.04 (+3.36%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$1.24 -0.01 (-0.43%)
As of 05/30/2025 06:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Vivani Medical EPS Results

Actual EPS
-$0.13
Consensus EPS
-$0.13
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Vivani Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Vivani Medical Announcement Details

Quarter
Q3 2023
Time
Before Market Opens
Conference Call Date
Tuesday, November 14, 2023
Conference Call Time
6:00AM ET

Upcoming Earnings

Vivani Medical's Q2 2025 earnings is scheduled for Tuesday, August 12, 2025, with a conference call scheduled at 12:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Vivani Medical Earnings Headlines

HC Wainwright Weighs in on Vivani Medical Q1 Earnings
How Trade Wars Are Creating Fresh Opportunities for Investors
Tariffs and trade tensions are back in the headlines, and while many are focused on the risks, smart investors know there’s also opportunity. New supply chain shifts, pricing power adjustments, and sector revaluations are already underway—creating openings for those who act early. That’s why we’ve just released our latest research: 📈 “From Tariffs to Returns: How to Capitalize on Trade Disputes in Your Portfolio”
See More Vivani Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Vivani Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vivani Medical and other key companies, straight to your email.

About Vivani Medical

Vivani Medical (NASDAQ:VANI), a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

View Vivani Medical Profile

More Earnings Resources from MarketBeat